OMER
Omeros Corporation

10,367
Mkt Cap
$582.8M
Volume
1.27M
52W High
$13.60
52W Low
$2.95
PE Ratio
-4.08
OMER Fundamentals
Price
$8.23
Prev Close
$8.22
Open
$8.39
50D MA
$6.13
Beta
1.40
Avg. Volume
7.38M
EPS (Annual)
-$2.70
P/B
-2.62
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Omeros (NASDAQ:OMER) Shares Down 5.6% - Should You Sell?
Omeros (NASDAQ:OMER) Shares Down 5.6% - Here's What Happened...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Omeros (NASDAQ:OMER) Stock Price Up 8.1% - Time to Buy?
Omeros (NASDAQ:OMER) Shares Up 8.1% - Here's What Happened...
MarketBeat·2d ago
News Placeholder
D. Boral Capital Reiterates "Buy" Rating for Omeros (NASDAQ:OMER)
D. Boral Capital reiterated a "buy" rating and set a $36.00 target price on shares of Omeros in a research note on Friday...
MarketBeat·4d ago
News Placeholder
Omeros (NASDAQ:OMER) Shares Gap Up - Here's Why
Omeros (NASDAQ:OMER) Shares Gap Up - Time to Buy...
MarketBeat·4d ago
News Placeholder
Omeros (NASDAQ:OMER) Cut to Sell at Wall Street Zen
Wall Street Zen cut shares of Omeros from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·5d ago
News Placeholder
Omeros (NASDAQ:OMER) Posts Earnings Results, Beats Estimates By $0.39 EPS
Omeros (NASDAQ:OMER - Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.34) earnings per share (EPS) for the quarter, topping analysts...
MarketBeat·5d ago
News Placeholder
Omeros Corporation Reports Third Quarter 2025 Financial Results
Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2025, which include: Net loss for the third...
Business Wire·7d ago
News Placeholder
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025
Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended September 30, 2025, on Thursday, November 13, 2025, after the market closes...
Business Wire·10d ago
News Placeholder
Weekly Stock Market Update: Apple, Taiwan Semiconductor and Novo Nordisk
It was a volatile but ultimately positive week on Wall Street, marked by renewed tensions in the U.S.-China trade war and a strong start to the earnings season. Major banks exceeded expectations...
TheStreet.com·1mo ago
News Placeholder
NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease Portfolio
Novo Nordisk's $2.1 billion deal for Omeros' zaltenibart aims to strengthen its rare disease pipeline amid GLP-1 market headwinds.
Zacks·1mo ago

Latest OMER News

View

Advertisement|Remove ads.

Advertisement|Remove ads.